Pembrolizumab-Induced Sclerosing Cholangitis

Clin Gastroenterol Hepatol. 2022 Feb;20(2):e18. doi: 10.1016/j.cgh.2020.11.048. Epub 2020 Dec 3.

Authors

Ali Dean Tahboub Amawi¹, William J Tremaine², Sudhakar K Venkatesh¹

Affiliations

¹ Division of Abdominal Imaging, Department of Radiology, Mayo Clinic, Rochester, Minnesota.
² Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

PMID: 33279784
DOI: 10.1016/j.cgh.2020.11.048

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Cholangitis, Sclerosing* / chemically induced
Humans

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab